Immunocore Holdings (IMCR) Treasury Shares (2023 - 2026)
Immunocore Holdings' (IMCR) quarterly Treasury Shares came in at $894326.0 in Q1 2026, up 84.34% year-on-year from $485140.0 in Q1 2025, and up 80.25% quarter-over-quarter from $496156.0 in Q4 2025.
Immunocore Holdings (IMCR) Treasury Shares (2023 - 2026) Analysis & Trends
Immunocore Holdings has disclosed Treasury Shares across 3 years of filings, most recently posting $894326.0 for Q1 2026.
- Treasury Shares for Q1 2026 came in at $894326.0, up 84.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $894326.0 (up 84.34% YoY), and the FY2025 annual result was $496156.0, changed N/A from the prior year.
- Treasury Shares came in at $894326.0 for Q1 2026 at Immunocore Holdings, up from $496156.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $894326.0 in Q1 2026 to a low of $20000.0 in Q4 2023.
- The 3-year median for Treasury Shares is $488548.5 (2025), against an average of $477928.7.
- Peak annual rise in Treasury Shares reached 84.34% in 2026, while the deepest fall reached 84.34% in 2026.
- Immunocore Holdings' Treasury Shares stood at $20000.0 in 2023, then soared by 2380.78% to $496156.0 in 2025, then jumped by 80.25% to $894326.0 in 2026.
- The last three Treasury Shares figures came in at $894326.0 (Q1 2026), $496156.0 (Q4 2025), and $491957.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - | - |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - | - |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - | - |
| 10 | Immunocore Holdings | 1.46 Bn | 616.35 Mn | 106.24 Mn | 894,326.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 894,326.00 |
| Mar 31, 2026 | 894,326.00 |
| Dec 31, 2025 | 496,156.00 |
| Dec 31, 2025 | 496,156.00 |
| Sep 30, 2025 | 491,957.00 |
| Sep 30, 2025 | 491,957.00 |
| Jun 30, 2025 | 479,993.00 |
| Jun 30, 2025 | 479,993.00 |
| Mar 31, 2025 | 485,140.00 |
| Mar 31, 2025 | 485,140.00 |
| Dec 31, 2023 | 20,000.00 |
| Dec 31, 2023 | 20,000.00 |